Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development

Author： Duong MyNgan   Nicholls Stephen J  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.7, 2009-07, pp. : 753-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New lipid-modifying therapies

By Bruckert Eric  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 325-335

Informa Healthcare

Access to resources Recommend Favorite

Unidirectional Inhibition of Lipid Transfer Protein I-Mediated Transfer of Cholesteryl Esters Between High-Density and Low-Density Lipoproteins by Amphotericin B Lipid Complex

By Sivak Olena   Lau Benny   Patankar Nilesh   Wasan Kishor M.  

Pharmaceutical Research, Vol. 21, Iss. 12, 2004-12 ,pp. : 2336-2339

Springer Publishing Company

Access to resources Recommend Favorite

Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid

By Schachter Michael  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 415-422

Springer Publishing Company

Access to resources Recommend Favorite

Comparative Study of Non-High Density Lipoproteins Cholesterol Level and Lipid Profile in Pre-Diabetic and Diabetic Patients

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 402-407

Bentham Science Publishers

Access to resources Recommend Favorite

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite